PGNY Progyny, Inc.

NEUTRAL Impact: 2/10 144
Horizon days Filed May 27, 2026 Processed 10d 9h ago SEC 0001959173-26-004031
Form 144 — notice of proposed sale of securities
Latest settled — T+5d ⚠ clustered
PGNY ▼ -1.41% at T+5d
NEUTRAL call ✗ call lost -1.41% · α vs SPY -2.62% · entry $25.48 → $25.12
Next anchor: T+20d in 18d
Last close $25.86 (close Jun 5) · +1.49% from $25.48 entry
Entry anchored
May 27, 11:25 AM ET
via Databento tick
T+1d
+0.82%
call +0.82% · α +0.27%
$25.69
settled 10d ago
T+5d
-1.41%
call -1.41% · α -2.62%
$25.12
settled 4d ago
T+20d
call — · α —
in 18d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Director Kevin K. Gordon filed a Form 144 notice of intent to sell 5,500 shares of Progyny (PGNY) at an estimated aggregate market value of $137,445. The shares were acquired via restricted stock vesting on May 22, 2026, and the sale is for compensation-related purposes. This is a routine insider sale by a director, not an executive officer, and represents a small fraction of the company's $2.0B market cap.

Actionable Insight

This is a routine director-level sale tied to equity compensation vesting. No material signal for the stock. Monitor for any acceleration of insider selling patterns, but this filing alone does not warrant action.

Key Facts

  • Director Kevin K. Gordon filed Form 144 to sell 5,500 shares of PGNY common stock.
  • Estimated aggregate market value of the proposed sale is $137,445.
  • Shares were acquired via restricted stock vesting on May 22, 2026.
  • The sale is for compensation-related purposes, not a discretionary open-market sale.
  • Gordon is a director, not an executive officer (CEO/CFO), reducing signaling weight.
  • The proposed sale represents ~0.18% of the company's $2.0B market cap.
  • No other insider sales or purchases in the prior 30 days were reported.

Financial Impact

Proposed sale of 5,500 shares worth ~$137,445, negligible relative to $2.0B market cap.

dilution

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur.
  • Director sales carry less signaling weight than C-suite sales.
  • No other insider activity to corroborate a bearish thesis.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Misc Health & Allied Services, NEC
Analyst Consensus
82% bullish (17 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-004031
Document: 0001959173-26-004031-index.html0001959173-26-004031
Document: 0001959173-26-004031.txt0001959173-26-004031
9 reports for PGNY
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PGNY — sortable, filterable
Type Now
Jun 3, 2026
3d ago
Insider Cluster
NEUTRAL ★ 3/10
$25.48 $25.86▲ +1.49%▲ +4.07%$25.86 (+1.49%)
Jun 3, 2026
3d ago
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+1
May 28, 2026
9d ago
Press Release
BEARISH ★ 6/10
$25.69 $25.56▲ +0.51%▲ +0.75%$25.86 (−0.66%)
May 27, 2026
10d ago
144
NEUTRAL ★ 2/10
$25.48 $25.69▲ +0.82%▲ +0.27%$25.86 (+1.49%)
May 26, 2026
11d ago
8-K
NEUTRAL ★ 4/10
$25.05 $25.48▲ +1.72%▲ +1.70%$25.86 (+3.23%)
May 21, 2026
16d ago
Insider Cluster
NEUTRAL ★ 3/10
$24.88 $25.05▲ +0.68%▲ +0.10%$25.86 (+3.94%)
May 21, 2026
16d ago
Insider Cluster
NEUTRAL ★ 2/10
awaiting T+1
Apr 23, 2026
6w ago
Press Release
NEUTRAL ★ 2/10
$17.67 $18.17▲ +2.83%▲ +2.04%$25.86 (+46.35%)
Apr 10, 2026
8w ago
DEFA14A
NEUTRAL ★ 3/10
$16.30 $16.98▲ +4.17%▲ +3.20%$25.86 (+58.65%)
Showing 9 of 9

US Market Status

Market Closed — Opens Mon (12h 13m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access